type here...

CATEGORIES

Healthcare

LATEST

1...676869...76Page 68 of 76

TRENDING

EDITORS CHOICE

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

Medika Life -
European Commission Approves Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent Anemia in Adult Patients with Myelodysplastic Syndromes or Beta Thalassemia

FDA Approves THERMOCOOL SMARTTOUCH® SF Ablation Catheter

Medika Life -
The CARTO® 3 System and THERMOCOOL SMARTTOUCH® SF Catheter allow for a patient-tailored ablation approach, resulting in high long-term effectiveness in persistent atrial fibrillation patients

From The Appeals Desk: The “30 Day Readmission” Denial

Dr. Hesham A. Hassaballa -
Insurance company denials are terribly frustrating. They delay prompt processing of claims. They require annoying extra steps to get paid. And, frequently, they require...

The Diversion of Drugs Within Healthcare Needs to be Addressed

Medika Life -
The Protenus Drug Diversion Digest found that over half of diversion incidents took place in a hospital, medical center, or physician practice setting

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories